The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome
Qiang Gao(Fudan University), Yuming Liu(Fudan University), Jiaqiang Ma(National University of Defense Technology), Lingyu Tian(Universität Hamburg), Xiaoming Zhang(Chinese Academy of Sciences), Guohe Song(Shanghai First People's Hospital), Xiaoying Wang(Xidian University), Jia Fan(Fudan University), Jian Zhou(Fudan University Shanghai Cancer Center), Shuaixi Yang(Fudan University), Jie-Yi Shi(Fudan University), Liangqing Dong(Fudan University), Jiao‐Men Pan(Fudan University)
Cited by 41
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|977
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
|Nature Metabolism|2023|540